From the targeted therapy's point of view, interestingly, a recent systematic review of genetic vulnerability across cancer cell lines identified ARID1B, the ARID1A mutually exclusive subunit in mSWI/SNF (BAF) complex, as the top gene required for cancer cell survival with inactivating ARID1A mutations [44]. The gene discussed is BANF1; the disease is cancer.